“…Effective null mutation of XRCC2 leads to a delay in (but not an absence of) RAD51 foci formation in hamster cells (Liu, 2002) and numerous studies have shown that various XRCC2 mutants are hypersensitive to DNA cross-linking agents such as mitomycin C (MMC), cisplatin, aldehydes, tirapazamine and temozolomide and that DNA replication fork dynamics are disturbed (Liu, 2002; Liu et al, 1998; Liu and Lim, 2005; Saxena et al, 2018; Wang et al, 2014). In Arabidopsis and more recently in Drosophila, XRCC2 has also been shown to be important for somatic recombination and DNA repair under genotoxic stress while having a minor or no evident role during meiosis (Bayer et al, 2020; Bleuyard et al, 2005; Da Ines et al, 2013a; Wang et al, 2014). This contrasts with mammalian studies where xrcc2 effective null mutations cause chromosome mis-segregation (Cui et al, 1999; Griffin et al, 2000; Mozdarani et al, 2001), developmental defects (Adam et al, 2007) and meiotic arrest and infertility (Griffin et al, 2000).…”